Source: International Congress 2019 – Airway disease-associated exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Çiftci (Ankara, Turkey), D. Dogan Mülazimoglu (Ankara, Turkey), S. Ayöz (Ankara, Turkey), B. Atasoy (Ankara, Turkey), E. Sen (Ankara, Turkey). What are the differences between moderate and severe COPD exacerbation groups?. 4298

Member's Comments

No comment yet.

Related content which might interest you: Are there any significant differences in the bacterial carrier of acute exacerbation of severe and very severe COPD according the degree of pulmonary functional impairment? Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006 Are severe and moderate exacerbations different entities? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Does inflammation decrease after recovery from severe exacerbation of COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 Both moderate and severe exacerbations accelerate physical activity decline in COPD patients Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017 Year: 2018 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Bronchiectasis in exacerbation of COPD: differences between genders Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Gender-specific differences in symptoms among patients with severe COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 A typical COPD exacerbation? Source: Breathe 2008; 4: 346-354 Year: 2008 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Differential dropout may affect exacerbation risk estimates differently in moderate-to-very severe COPD Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015